Clinical Academic Training Fellowship
The Institute of Cancer Research (ICR) and Imperial College London are pleased to invite expressions of interest for Clinical Academic Training Fellowships, starting in the 2021/22 academic year.
These prestigious fellowships aim to support the training of future clinical academic leaders in cancer research. They provide exceptional opportunity to expose clinical trainees to world class training in fundamental cell and molecular biology, therapeutics, radiotherapy, surgery and also to convergence science through the Cancer Research UK Convergence Science Centre at the ICR and Imperial. This will provide clinical academics with the expertise to discover, develop and deliver the next generation of treatments, technologies and methodologies into clinical care.
What is available?
Four highly competitive ICR and/or Imperial-based CRUK-funded fellowships are available in 2021.
Fellowships are typically three years in duration and provide the following:
- A clinical salary
- PhD registration fees at the UK rate
- Research running costs
Please read the attached guidance carefully before initiating the process.
|Milestone||Deadline (all deadlines 17:00)|
|Deadline for expression of interest from supervisors||14th September 2020|
|Candidates contact supervisors with whom they wish to develop a proposal||20th September to 19th October 2020|
|Deadline for full joint application with project proposal||14th December 2020|
|Outcome of full application submission||8th January 2021|
|Panel interviews held||Early February 2021|
|Expected start date of fellows||Autumn 2021|
Expression of Interest (EOI) requirements
Potential supervisors should submit the following as an EOI:
1) A broad project title/area
2) A short paragraph outlining the project area, in general up 250-300 words is sufficient
3) Details of the supervisory team
4) Any clinical specialties particularly required
EOIs should be submitted by email to firstname.lastname@example.org
Successful submissions will be advertised via the ICR and Imperial websites and via external channels.
Further details and frequently asked questions can be found in the attached guidance document.